Public Survey on Breath Testing for Health and Disease
Launched by IMPERIAL COLLEGE LONDON · Oct 6, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is a public survey that aims to understand people's interest in using breath tests for monitoring health and detecting diseases, including cancer. The researchers want to gather information about how comfortable and open the public is to the idea of breath testing as a health tool.
Anyone over the age of 18 can participate in this survey, so if you or someone you know is an adult, you are eligible to take part. Participants will be asked to share their thoughts and feelings about breath tests and their potential role in health care. This is a great opportunity to contribute to important research that could influence future health monitoring methods!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Member of the public above the age of 18
- Exclusion Criteria:
- • Member of the public below the age of 18
About Imperial College London
Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
George Hanna, PhD
Study Director
Imperial College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported